Innoforce is a biopharma manufacturing firm that facilitates the development and commercialization of innovative medicines. Founded by Yuling (Elaine) Li in 2018, Innoforce Pharmaceuticals is backed by CICC, Advantech Capital, Quan Capital, TriWise Capital, and Yanchuang Capital and is headquartered in Hangzhou.